FUREN Group Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 2,890.517 million compared to CNY 5,171.086 million a year ago. Operating loss was CNY 1,378.330 million compared to operating Income of CNY 318.250 million a year ago. Net loss was CNY 1,292.517 million compared to net income of CNY 149.533 million a year ago. Basic loss per share from continuing operations was CNY 2.06 compared to basic earnings per share from continuing operations of CNY 0.24 a year ago.